{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T07:47:52Z","timestamp":1790063272651,"version":"4.0.1"},"reference-count":23,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Heart Journal"],"published-print":{"date-parts":[[2012,11]]},"DOI":"10.1016\/j.ahj.2012.08.002","type":"journal-article","created":{"date-parts":[[2012,10,16]],"date-time":"2012-10-16T03:47:41Z","timestamp":1350359261000},"page":"750-755.e1","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Is heart failure guideline adherence being underestimated? The impact of therapeutic contraindications"],"prefix":"10.1016","volume":"164","author":[{"given":"Brett D.","family":"Atwater","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy M.","family":"Allen-Lapointe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sana M.","family":"Al-Khatib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise O.","family":"Zimmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gillian D.","family":"Sanders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric D.","family":"Peterson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ahj.2012.08.002_bb0005","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1002\/clc.4960271204","article-title":"Cardiac resynchronization therapy in patients with heart failure and conduction abnormalities other than left bundle-branch block: analysis of the Multicenter InSync Randomized Clinical Evaluation (MIRACLE)","volume":"27","author":"Aranda","year":"2004","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.ahj.2012.08.002_bb0010","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1161\/CIRCULATIONAHA.108.191259","article-title":"Heart disease and stroke statistics\u20142009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee","volume":"119","author":"Lloyd-Jones","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2012.08.002_bb0015","first-page":"1","article-title":"National Hospital Discharge Survey: 2003 annual summary with detailed diagnosis and procedure data","author":"Kozak","year":"2006","journal-title":"Vital Health Stat 13"},{"key":"10.1016\/j.ahj.2012.08.002_bb0020","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1056\/NEJM199108013250501","article-title":"Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure","volume":"325","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2012.08.002_bb0025","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1056\/NEJM199209033271001","article-title":"Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction","volume":"327","author":"Pfeffer","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2012.08.002_bb0030","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1016\/S0140-6736(99)04440-2","article-title":"Effect of metoprolol CR\/XL in chronic heart failure: Metoprolol CR\/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)","volume":"353","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.ahj.2012.08.002_bb0035","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0140-6736(98)11181-9","article-title":"The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial","volume":"353","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.ahj.2012.08.002_bb0040","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1056\/NEJM200105313442201","article-title":"Effect of carvedilol on survival in severe chronic heart failure","volume":"344","author":"Packer","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2012.08.002_bb0045","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","article-title":"The effect of spironolactone on morbidity and mortality in patients with severe heart failure","volume":"341","author":"Pitt","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2012.08.002_bb0050","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1056\/NEJMoa043399","article-title":"Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure","volume":"352","author":"Bardy","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2012.08.002_bb0055","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1056\/NEJMoa013474","article-title":"Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction","volume":"346","author":"Moss","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2012.08.002_bb0060","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1056\/NEJMoa050496","article-title":"The effect of cardiac resynchronization on morbidity and mortality in heart failure","volume":"352","author":"Cleland","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2012.08.002_bb0065","first-page":"e391","article-title":"2009 Focused Update Incorporated Into the ACC\/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults","volume":"119","author":"Hunt","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2012.08.002_bb0070","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.jacc.2007.04.064","article-title":"Characteristics, treatments, and outcomes of patients with preserved systolic function hospitalized for heart failure: a report from the OPTIMIZE-HF Registry","volume":"50","author":"Fonarow","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2012.08.002_bb0075","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1161\/CIRCULATIONAHA.109.934471","article-title":"Improving evidence-based care for heart failure in outpatient cardiology practices: primary results of the Registry to Improve the Use of Evidence-Based Heart Failure Therapies in the Outpatient Setting (IMPROVE HF)","volume":"122","author":"Fonarow","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2012.08.002_bb0080","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1001\/jama.2009.1493","article-title":"Use of aldosterone antagonists in heart failure","volume":"302","author":"Albert","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.ahj.2012.08.002_bb0085","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1016\/S0735-1097(02)01840-5","article-title":"Impact of beta-blocker treatment on the prognostic value of currently used risk predictors in congestive heart failure","volume":"39","author":"Zugck","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2012.08.002_bb0090","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.cardfail.2010.04.004","article-title":"HFSA 2010 Comprehensive Heart Failure Practice Guideline","volume":"16","author":"Lindenfeld","year":"2010","journal-title":"J Card Fail"},{"key":"10.1016\/j.ahj.2012.08.002_bb0095","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1093\/eurheartj\/ehs104","volume":"33","author":"McMurray","year":"2012","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ahj.2012.08.002_bb0100","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1007\/s11606-011-1745-2","article-title":"Age and receipt of guideline-recommended medications for heart failure: a nationwide study of veterans","volume":"26","author":"Steinman","year":"2011","journal-title":"J Gen Intern Med"},{"key":"10.1016\/j.ahj.2012.08.002_bb0105","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1001\/archinte.164.11.1186","article-title":"Provider and hospital characteristics associated with geographic variation in the evaluation and management of elderly patients with heart failure","volume":"164","author":"Havranek","year":"2004","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ahj.2012.08.002_bb0110","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.amjcard.2005.09.139","article-title":"Adherence to American College of Cardiology\/American Heart Association Guidelines for the Management of Anticoagulation in Patients With Mechanical Valves Undergoing Elective Outpatient Procedures","volume":"97","author":"Kirtane","year":"2006","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ahj.2012.08.002_bb0115","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1161\/CIRCOUTCOMES.110.958603","article-title":"Extent of and reasons for nonuse of implantable cardioverter defibrillator devices in clinical practice among eligible patients with left ventricular systolic dysfunction","volume":"4","author":"LaPointe","year":"2011","journal-title":"Circ Cardiovasc Qual Outcomes"}],"container-title":["American Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870312005303?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870312005303?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T05:48:45Z","timestamp":1757569725000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002870312005303"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11]]},"references-count":23,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012,11]]}},"alternative-id":["S0002870312005303"],"URL":"https:\/\/doi.org\/10.1016\/j.ahj.2012.08.002","relation":{},"ISSN":["0002-8703"],"issn-type":[{"value":"0002-8703","type":"print"}],"subject":[],"published":{"date-parts":[[2012,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Is heart failure guideline adherence being underestimated? The impact of therapeutic contraindications","name":"articletitle","label":"Article Title"},{"value":"American Heart Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ahj.2012.08.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Mosby, Inc. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}